Moderna, Inc. (MRNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 700M 1.4B 2.1B Q3 '24: 1.9B Q4 '24: 966M Q1 '25: 108M Q2 '25: 142M Q3 '25: 1B Q4 '25: 678M Q1 '26: 389M Q2 '26: 145M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '24: -70M Q4 '24: -1.2B Q1 '25: -1.1B Q2 '25: -907M Q3 '25: -260M Q4 '25: -857M Q1 '26: -1.4B Q2 '26: -815M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '24: 13M Q4 '24: -1.1B Q1 '25: -971M Q2 '25: -825M Q3 '25: -200M Q4 '25: -826M Q1 '26: -1.3B Q2 '26: -782M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 350M 700M 1.1B Q3 '24: 514M Q4 '24: 739M Q1 '25: 90M Q2 '25: 119M Q3 '25: 207M Q4 '25: 452M Q1 '26: 955M Q2 '26: 93M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '24: -1.6B Q4 '24: 825M Q1 '25: -1B Q2 '25: -919M Q3 '25: -847M Q4 '25: 930M Q1 '26: -630M Q2 '26: -526M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '24: -1.7B Q4 '24: 303M Q1 '25: -1.2B Q2 '25: -922M Q3 '25: -880M Q4 '25: 891M Q1 '26: -692M Q2 '26: -563M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '24: 382M Q2 '24: 384M Q3 '24: 399M Q1 '25: 386M Q2 '25: 388M Q3 '25: 390M Q1 '26: 395M Q2 '26: 398M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '24: -5.81 Q4 '24: -9.28 Q1 '25: -8.73 Q2 '25: -7.53 Q3 '25: -8.07 Q4 '25: -7.27 Q1 '26: -8.15 Q2 '26: -7.99 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.